Sangamo Therapeutics, Inc.
Methods and compositions for the treatment of Fabry disease

Last updated:

Abstract:

Nucleases and methods of using these nucleases for inserting a sequence encoding a therapeutic .alpha.-Gal A protein such as an enzyme into a cell, thereby providing proteins or cell therapeutics for treatment and/or prevention of Fabry disease.

Status:
Grant
Type:

Utility

Filling date:

19 Oct 2017

Issue date:

11 Jan 2022